We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+9.48%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$5.41B
AUM Growth
+$1.18B
Cap. Flow
+$984M
Cap. Flow %
18.18%
Top 10 Hldgs %
20.49%
Holding
1,162
New
152
Increased
695
Reduced
244
Closed
54

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$64.8M
2
JD icon
JD.com
JD
+$44.9M
3
MELI icon
Mercado Libre
MELI
+$40.5M
4
NTES icon
NetEase
NTES
+$38M
5
BEKE icon
KE Holdings
BEKE
+$21.5M

Top Sells

Rank Stock Value
1
FUTU icon
Futu Holdings
FUTU
+$21.6M
2
TCOM icon
Trip.com Group
TCOM
+$20.5M
3
AOD
abrdn Total Dynamic Dividend Fund
AOD
+$12.1M
4
GDV icon
Gabelli Dividend & Income Trust
GDV
+$12M
5
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
+$11.2M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.21%
2 Technology 22.71%
3 Communication Services 13.35%
4 Financials 4.97%
5 Industrials 4.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDTX icon
976
Black Diamond Therapeutics
BDTX
$112M
$19K ﹤0.01%
820
-5
-0.6% -$135
SOS
977
SOS Limited
SOS
$14.6M
$19K ﹤0.01%
5
+3
+150% +$11.8K
AERI
978
DELISTED
Aerie Pharmaceuticals
AERI
$19K ﹤0.01%
1,065
-10
-0.9% -$173
COLL icon
979
Collegium Pharmaceutical
COLL
$956M
$18K ﹤0.01%
785
-10
-1% -$238
FRT icon
980
Federal Realty Investment Trust
FRT
$10.3B
$18K ﹤0.01%
183
+26
+17% +$2.51K
FSLR icon
981
First Solar
FSLR
$26.9B
$18K ﹤0.01%
213
+34
+19% +$3.12K
RNAM
982
DELISTED
Avidity Biosciences
RNAM
$18K ﹤0.01%
845
-25
-3% -$612
VNDA icon
983
Vanda Pharmaceuticals
VNDA
$302M
$18K ﹤0.01%
1,245
-10
-0.8% -$162
TCRR
984
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$18K ﹤0.01%
855
+90
+12% +$2.45K
AN icon
985
AutoNation
AN
$6.92B
$17K ﹤0.01%
185
-3,984
-96% -$319K
ESPR
986
DELISTED
Esperion Therapeutics
ESPR
$17K ﹤0.01%
635
-5
-0.8% -$148
KPTI icon
987
Karyopharm Therapeutics
KPTI
$48M
$17K ﹤0.01%
113
– –
TCRT icon
988
Alaunos Therapeutics
TCRT
$4.86M
$17K ﹤0.01%
32
-1
-3% -$623
ICPT
989
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$17K ﹤0.01%
750
-15
-2% -$418
ADAP
990
DELISTED
Adaptimmune Therapeutics
ADAP
$16K ﹤0.01%
3,100
-80
-3% -$458
CGEN icon
991
Compugen
CGEN
$228M
$16K ﹤0.01%
1,900
-40
-2% -$444
CLVS
992
DELISTED
Clovis Oncology, Inc.
CLVS
$16K ﹤0.01%
2,365
+340
+17% +$2.28K
GOSS icon
993
Gossamer Bio
GOSS
$87M
$15K ﹤0.01%
1,710
-45
-3% -$454
IDYA icon
994
IDEAYA Biosciences
IDYA
$3.56B
$15K ﹤0.01%
660
-5
-0.8% -$97
LEGN icon
995
Legend Biotech
LEGN
$4.01B
$15K ﹤0.01%
540
+50
+10% +$1.36K
HARP
996
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$15K ﹤0.01%
73
+13
+22% +$2.61K
PRVB
997
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$15K ﹤0.01%
1,435
+115
+9% +$1.62K
KDMN
998
DELISTED
Kadmon Holdings, Inc.
KDMN
$15K ﹤0.01%
3,900
-35
-0.9% -$160
BYND icon
999
Beyond Meat
BYND
$277M
$14K ﹤0.01%
113
+18
+19% +$2.65K
INGR icon
1000
Ingredion
INGR
$6.58B
$14K ﹤0.01%
160
+24
+18% +$2.05K
38 39
40
41 42

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Penserra Capital Management held 1,162 positions worth $5.41B, up 28% from $4.23B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Penserra Capital Management deployed $984M of net new capital in Q1 2021, opening 152 new positions and adding to 695 existing holdings. Its largest new stake was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Futu Holdings, an estimated $21.6M trimmed.

  • Penserra Capital Management's largest Q1 2021 buy was BlackRock Resources & Commodities Strategy Trust: 1,847,500 shares worth $16.4M.
  • Penserra Capital Management added most to Alibaba in Q1 2021, an estimated $64.8M increase.
  • Penserra Capital Management's biggest Q1 2021 reduction was Futu Holdings, cutting an estimated $21.6M.
  • Penserra Capital Management fully exited abrdn Total Dynamic Dividend Fund in Q1 2021, selling an estimated $12.1M.
  • Penserra Capital Management's ten largest holdings make up 20% of its $5.41B portfolio in Q1 2021.
  • Penserra Capital Management opened 152 new positions and closed 54 in Q1 2021.
  • Penserra Capital Management's portfolio value rose 28% quarter-over-quarter to $5.41B.

Based on Penserra Capital Management's 13F filing for Q1 2021, filed 13 May 2021.